• 1-888-889-8997
  • info@biomedix.com
  • Remote Support
Biomedix
  • About Us
    • Affiliates
    • Biomedix Customer Service
    • Careers
    • Contact Us
    • History
    • PARTNERS Program
  • Biomedix Xchange
    • Behavioral Health
      • Depression
      • Personality Disorder
    • Chronic Conditions
      • COPD – Chronic obstructive pulmonary disease
      • Diabetic Retinopathy
      • Osteoporosis
      • PAD – Peripheral Artery Disease
        • Peripheral Artery Disease Prevalence
        • PAD Symptoms
      • Peripheral Neuropathy
    • Social Determinants of Health (SDoH)
  • Products
    • BeamMed MiniOmni
    • Biomedix PADnet
    • Biomedix PADnet Xpress
    • IRIS Testing for Diabetic Retinopathy
    • NDD Medical Spirometers
    • NeuroMetrix DPNCheck
    • O’Brien ETF128 and ETFMX
  • Blog
  • Store

The Amazonification Of Heathcare: Transforming To A Patient-Obsessed Practice

Published by Christian Trygstad on September 14, 2020September 14, 2020

Join us for a special webinar in honor of September being PAD Awareness Month featuring vascular specialist Dr. “Romi” Chopra. Register today to secure your spot.

Categories: Company News

Recent Posts
  • CMS 2023 Medicare Advantage Final Rule Requires Collection of Social Risk Factors
  • New study confirms the clinical effectiveness of ETF for diabetic foot ulcer development
  • Biomedix at RISE National – Stop by to checkout PADnet Xpress
Archives
  • May 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • February 2019
  • January 2019
  • November 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
Socials
  • Facebook
  • Twitter
  • Linkedin
  • YouTube

Related Posts

O'Brien ETF 128 being used on a patient to identify peripheral neuropathy
Company News

New study confirms the clinical effectiveness of ETF for diabetic foot ulcer development

A study recently published in the Journal of the American Podiatric Medical Association examined the combined utility of a timed vibration test (TVT) combined with monofilament, and compared the effectiveness of using these technologies separately Read more…

RISE National Masthead
Company News

Biomedix at RISE National – Stop by to checkout PADnet Xpress

Stop by booth 308 to check out PADnet Xpress, the world’s best cuff-free vascular disease diagnostic technology. Make sure to stop by our roundtable 8-9am on Wednesday, March 9th, titled: Boosting HCC capture and gap Read more…

Company News

Biomedix At ACFAS 2022

If you are going to ACFAS February 24th-26th, schedule some time to meet with the Biomedix team, we’ll be there! Schedule A Time

Contact Us:

Phone: 888-889-8997

Email: support@biomedix.com

Recent Blog Posts
  • CMS 2023 Medicare Advantage Final Rule Requires Collection of Social Risk Factors
  • New study confirms the clinical effectiveness of ETF for diabetic foot ulcer development
  • Biomedix at RISE National – Stop by to checkout PADnet Xpress
  • Almost half of CLI hospitalizations are among adults under 65
  • Biomedix At ACFAS 2022
Search Biomedix.com
  • Facebook
  • Twitter
  • Linkedin
  • YouTube

  • CRM
  • e
  • Terms & Conditions
  • Sitemap
Copyright © 2022 Biomedix by Collaborative Care Diagnostics, LLC. All Rights Reserved.